Balance Sheet
Accounts PayablesAccumulated ExpensesCommon EquityConvertible DebtLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsPayablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
EBIATLong-Term Debt IssuancesShares OutstandingShares Outstanding
Ratios

Medicale (MCLE) Shares Outstanding (2020 - 2025)

Medicale's Shares Outstanding history spans 6 years, with the latest figure at $5.9 million for Q2 2025.

  • For Q2 2025, Shares Outstanding changed 0.0% year-over-year to $5.9 million; the TTM value through Jun 2025 reached $5.9 million, changed 0.0%, while the annual FY2024 figure was $5.9 million, 0.0% changed from the prior year.
  • Shares Outstanding reached $5.9 million in Q2 2025 per MCLE's latest filing, roughly flat from $5.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $5.9 million in Q1 2021 to a low of $5.9 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $5.9 million, with a median of $5.9 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: skyrocketed 74.12% in 2021, then changed 0.0% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $5.9 million in 2021, then changed by 0.0% to $5.9 million in 2022, then changed by 0.0% to $5.9 million in 2023, then changed by 0.0% to $5.9 million in 2024, then changed by 0.0% to $5.9 million in 2025.
  • Per Business Quant, the three most recent readings for MCLE's Shares Outstanding are $5.9 million (Q2 2025), $5.9 million (Q1 2025), and $5.9 million (Q4 2024).